The Lancet Oncology and The Lancet Infectious DiseasesMarch 27, 2002THE LANCET ONCOLOGY THE TRUE COST OF A NUCLEAR DETERRENT This month’s editorial covers the recent leaked report from the US Department of Health and Disease Control, showing the patterns of nuclear fallout across the US resulting from Cold War testing. The editorial discusses the impact of these data on cancer incidence and the worldwide effects of nuclear testing on the general population and military personnel. It concludes: ‘It is easy to say that lessons should be learnt from the history of the nuclear deterrent, but unfortunately, with the escalation of the nuclear race in India and Pakistan, and the possibility of terrorist groups such as al-Qaeda acquiring materials to create crude nuclear devices, it is likely that the same mistakes will be repeated. We may never fully realise the true human cost of military advancement.’ REVIEWS · The evolution of tamoxifen therapy in breast cancer: selective oestrogen-receptor modulators and downregulators · Use of minimally invasive oesophagectomy for cancer of the oesophagus · Clinical management of dyspnoea · Mediastinal (thymic) large B-cell lymphoma: where do we stand? · Culprit and victim - DNA topoisomerase II · Cancer causation: the Darwinian downside of past success? · THE LANCET INFECTIOUS DISEASES ENOUGH TIME WASTED IN SOUTH AFRICA This month’s Leading Edge editorial discusses the South African Government’s reluctance to provide the antiretroviral drug nevirapine to pregnant women with HIV. The drug has been shown to be effective in preventing mother-to-child HIV-1 transmission; however the South African Government have recently launched an appeal to a March 11 court hearing which instructed them to make the drug available in state facilities offering HIV-1 counselling and testing. REVIEWS · Epidemiology of drug-resistant malaria · p values for pathogens: statistical inference from infectious-disease data · Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis · Multiplexed immunoassays by flow cytometry for diagnosis and surveillance of infectious diseases in resource-poor settings · Sequencing the Aspergillus fumigatus genome Lancet |
|||||||||||||||||||||
| Related Cancer Current Events and Cancer News Articles Menopause-cardiology consensus statement on cardiovascular disease and on HRT A menopause-cardiology consensus statement has called for direct action to prevent cardiovascular disease (CVD) in menopausal women. The statement also concludes that there is little evidence of increased CVD risk in taking HRT. Other Illnesses, Body Weight Do Not Explain Racial Disparities in Colon Cancer Survival, UAB Researchers Say A new study by University of Alabama at Birmingham (UAB) researchers shows that body-mass index (BMI) and co-existing medical conditions (co-morbidity) do not explain the decreased survival observed among African-Americans compared to Caucasians who also have colon cancer. Multiple health concerns surface as winter, vitamin D deficiences arrive A string of recent discoveries about the multiple health benefits of vitamin D has renewed interest in this multi-purpose nutrient, increased awareness of the huge numbers of people who are deficient in it, spurred research and even led to an appreciation of it as "nature's antibiotic." AIDS research reveals a lack of family-planning programs in Uganda University of Alberta graduate student Jennifer Heys wants to make her message clear: there needs to be more education in Ugandan communities about contraception. Possible Link Studied Between Childhood Abuse and Early Cellular Aging Children who suffer physical or emotional abuse may be faced with accelerated cellular aging as adults, according to new research from Butler Hospital and Brown University. Rare pancreatic cancer patients may live longer when treated with radiation therapy Radiation therapy is effective in achieving local control and palliation in patients with pancreatic neuroendocrine tumors (PNTs), despite such tumors being commonly considered resistant to radiation therapy. Researchers Identify Role of Gene in Tumor Development, Growth and Progression Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis. Saving the single cysteine: new antioxidant system found We've all read studies about the health benefits of having a life partner. The same thing is true at the molecular level, where amino acids known as cysteines are much more vulnerable to damage when single than when paired up with other cysteines. Gene mismatch influences success of bone marrow transplants A commonly inherited gene deletion can increase the likelihood of immune complications following bone marrow transplantation, an international team of researchers reports in the November 22 advance online issue of Nature Genetics. Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer Agios Pharmaceuticals today announced that its scientists have established, for the first time, that the mutated IDH1 gene has a novel enzyme activity consistent with a cancer-causing gene, or oncogene. More Cancer Current Events and Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||